Search filters

Filters

Clear All

Phase

  • 1
  • 1
  • 3
  • 4
  • 8
  • 18
  • 3
  • 18

Found 18 Kidney Disease trials

A listing of Kidney Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Kidney Transplantation in Recipients and Donors with HIV: Long Term Follow up Study

18 years - 99 years
All genders
Interventional
The purpose of this study is to study how well patients that receive a kidney from an HIV+ organ donor do over 10 years compared to patients that receive a kidney from an HIV- donor. People 18 years of age and older with end-stage renal disease and HIV, and who …
 Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging  HIV Infection and Inflammation

Long-Term Follow-up of Older HIV-infected Adults in the ACTG: Addressing Issues of Aging HIV Infection and Inflammation

40 years - 99 years
All genders
Interventional
This study will look at the relationships between HIV infection, age and the immune system, and how these relate to the development of non-infectious illnesses such as heart disease, kidney disease, cancer, memory problems, and diabetes. Further, we will look at how demographic factors, behaviors, and social factors like social …
 FALCON- TRIAL OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

FALCON- TRIAL OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE

18 years - 70 years
All genders
Phase 3
Autosomal dominant polycystic kidney disease (ADPKD) is a multi-organ disorder that results in clusters of fluid-filled cysts in the kidneys and other organs leading to progressive enlargement and loss of organ function. ADPKD is a genetic disorder caused by mutations in the PKD1 and PKD2 genes, which encode the proteins …
 Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Patients With IgA Nephropathy Who Have Completed Study Nef-301

Study to Evaluate the Efficacy and Safety of Nefecon Treatment in Patients With IgA Nephropathy Who Have Completed Study Nef-301

18 years - 99 years
All genders
Interventional
This is a Phase 3b, multicenter, open-label extension (OLE) study to evaluate the efficacy and safety of Nefecon treatment in patients with IgAN who have completed the Phase 3 Study Nef 301 and continue to be treated with a stable dose of RAS inhibitor therapy (ACEIs and/or ARBs). Patients who …
 HOPE Trial

HOPE Trial

18 years - 99 years
All genders
HOPE is a randomized clinical trial that will evaluate approaches to reducing pain and opioid use among patients with chronic pain who are receiving maintenance hemodialysis for end-stage renal disease. The hypothesis is that pain coping skills training will be effective at reducing pain and opioid use, and that buprenorphine …
 REBOOT- Combination of Belimumab with Rituximab for Primary MN

REBOOT- Combination of Belimumab with Rituximab for Primary MN

18 years - 99 years
All genders
Phase 2
The main purpose of this study is to learn if the combination of belimumab and rituximabtreatment is more effective in making and keeping Primary MN inactive compared totreatment with rituximab alone.This is a three-year research study for people with primary membranous nephropathy(Primary MN). The study may require up to 24 …
 Non-Dipping Hypertension and The Human Chronobiome

Non-Dipping Hypertension and The Human Chronobiome

18 years - 99 years
All genders
Phase 1
Interventional
Do you have high nighttime blood pressure? Are you healthy, but interested in having a blood pressure study? Penn Medicine is seeking study participants 18years of age and older to have their blood pressure, physical activity, mobility, heart health, and social behavior monitored over 24 hours on two occasions. This …
11 - 18 of 18